CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 23 enrolled
Drug / intervention
pulmicortdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01197612
NCT01197612Phase 3Completed
CompareCT.gov

Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis

University of Michigan·interventional·Posted Sep 9, 2010·Updated May 29, 2018

In Brief

A Phase 3 clinical trial evaluating pulmicort for Chronic Sinusitis and Polyposis. Completed, enrolled 23 participants across 1 site.

Detailed Summary

That high-dose steroid applied to the nasal cavity immediately post-operatively will improve olfaction and healing following endoscopic sinus surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Sinusitis, Polyposis
CountriesUnited States
CollaboratorsAmerican Rhinologic Society

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 9, 2010
Enrollment StartSep 1, 2010
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.8 years ago

Interventions

pulmicortdrug

applied to nasal packing after surgery